Diamines & Chemicals Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing a challenging operational environment with significant losses across both standalone and consolidated financials.

Financial Performance Overview

The company's financial performance showed marked deterioration compared to the previous year. On a consolidated basis, the company reported substantial losses while experiencing a significant decline in revenue from operations.

Quarterly Results Analysis

The third quarter results highlighted operational challenges with revenue declining significantly year-over-year. Total income on a consolidated basis fell to ₹816.60 crores from ₹1,828.47 crores in Q3FY25. Other income also decreased to ₹52.73 crores compared to ₹77.47 crores in the corresponding quarter last year.

Expenses remained elevated at ₹1,160.09 crores, resulting in a loss before tax of ₹343.49 crores compared to a profit before tax of ₹123.84 crores in Q3FY25. The company's earnings per share turned negative at ₹3.48 per share compared to a positive ₹0.77 per share in the previous year quarter.

Nine-Month Performance

The nine-month period ending December 31, 2025, reflected sustained operational difficulties. Consolidated revenue from operations declined to ₹2,919.20 crores from ₹5,353.83 crores in the corresponding nine-month period of the previous year.

Segment Performance

The company operates through two reportable segments: Speciality Chemicals and Trading in Fruits and Vegetables. The Speciality Chemicals segment generated the entire revenue of ₹763.87 crores in Q3FY26, while the Trading in Fruits and Vegetables segment remained inactive during the quarter. In Q3FY25, the Speciality Chemicals segment had contributed ₹1,705.91 crores while Trading in Fruits and Vegetables added ₹45.09 crores.

Segment results showed losses before tax and finance costs of ₹330.10 crores for Speciality Chemicals in Q3FY26 compared to a profit of ₹97.23 crores in Q3FY25.

Corporate Developments

The Board of Directors approved the unaudited financial results in their meeting held on February 12, 2026. The company also reviewed and approved its Related Party Policy under Regulation 23 of SEBI (LODR) (Fifth Amendment) Regulations, 2025. The trading window for directors and designated employees was closed from January 01, 2026, and reopened on February 15, 2026, in compliance with insider trading regulations.

The company made a provision of ₹4.62 lakhs due to the impact of new Labour Codes implemented by the Government of India effective from November 21, 2025. The results include the consolidated performance of Diamines and Chemicals Limited, its wholly-owned subsidiary DAACL Fine Chem Limited, and share of loss from associate KLJ Organic Diamines Limited.

Diamines & Chemicals has announced receiving regulatory approval from the Gujarat Pollution Control Board (GPCB) for a product mix amendment at its existing manufacturing facility. The company disclosed this development under Regulation 30 of SEBI regulations on January 22, 2026.

Regulatory Approval Details

The company received the Product Mix Consolidated Consent & Authorization (CC&A) Amendment on January 21, 2026. This approval enables Diamines and Chemicals Limited to set up industrial plant activities in its existing manufacturing unit for the production of new items and products as specified in the detailed order AWH-151692.

Business Impact and Significance

According to the company's disclosure, the CC&A serves as the final permission to manufacture new products and is expected to contribute to an increase in total production capacity. This regulatory clearance allows the company to expand its product portfolio within its existing manufacturing infrastructure.

Compliance and Disclosure

The announcement was made in compliance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, which requires disclosure for granting, withdrawal, surrender, cancellation, or suspension of key licenses or regulatory approvals. Company Secretary Hemaxi Pawar signed the disclosure document on January 22, 2026.

Manufacturing Unit Enhancement

The consent specifically covers the setting up of industrial plant activities in the company's existing manufacturing unit. This approach allows Diamines and Chemicals Limited to leverage its current infrastructure while expanding its manufacturing capabilities for new product lines as detailed in the GPCB order.